Sign Up to like & get
recommendations!
0
Published in 2020 at "Anti-Cancer Drugs"
DOI: 10.1097/cad.0000000000000912
Abstract: Cyclophosphamide is an inert prodrug converted into 4-hydroxycyclophosphamide (OHCP) by hepatic hydroxylation. OHCP is in equilibrium with its tautomeric aldophosphamide (ALDO). From ALDO, the cytotoxic active metabolites are formed enzymatically by phosphodiesterases; these are the…
read more here.
Keywords:
toxicity;
pam;
causes possibilities;
aldo ... See more keywords